OrthAlign receives FDA 510(k) clearance for handheld THA application
Click Here to Manage Email Alerts
Key takeaways:
- OrthAlign Inc. announced FDA clearance of its Lantern handheld hip arthroplasty technology.
- The device is designed to improve positioning and navigation for direct anterior hip arthroplasty procedures.
OrthAlign Inc. announced it received FDA 510(k) clearance for its Lantern hip handheld technology for use in total hip arthroplasty procedures, according to a company press release.
The Lantern hip application is a handheld device that includes accelerometers and gyroscopes to improve positioning and navigation for direct anterior THA in the supine position, according to the release. The Lantern platform includes existing applications for total, revision and partial knee arthroplasties.
“Adding the total hip application to the Lantern platform is an enhancement that not only broadens our capabilities, but also reinforces our commitment to providing innovative solutions,” Eric Timko, chair and CEO of OrthAlign, said in the release. “As technology becomes the standard of care in total joint replacement, it’s essential to deliver solutions that are clinically, operationally and economically efficient. Lantern knee and balance have been a great success for OrthAlign and now, with Lantern hip, surgeons can confidently and easily take technology to any site of service for their total hip replacements. I applaud our internal team and surgeon advisors for the countless hours spent developing a product that we expect will make a positive impact on health care.”
Read more about
Click Here to Manage Email Alerts